能倍乐多少钱一瓶？

Respimat is suitable for the maintenance treatment of chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, the maintenance treatment of dyspnea and the prevention of acute exacerbations. It has synergistic and complementary effects when combined with β2 receptor agonists; anticholinergic drugs have a slow peak time and cannot be used alone to treat acute severe asthma or COPD.

Respimat is a classic drug for the treatment of stable COPD. On this basis, Boehringer Ingelheim has specially developed a new inhaled long-acting β2 receptor agonist olodaterol.

Respimat has been officially approved by the China Food and Drug Administration and is suitable for long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD, referred to as COPD, including chronic bronchitis and emphysema) to relieve symptoms.

A large amount of clinical research data proves that Respimat can provide better curative effects for patients with COPD, including controlling symptoms of COPD, reducing the risk of acute exacerbation, improving patients' quality of life, and is also safer. More studies have proven that dual-branch dilators can reduce the risk of acute exacerbations compared with ICS/LABA; and unlike other dual-branch dilators, Respimat can prevent acute exacerbations of chronic obstructive pulmonary disease.

How much does a bottle of Nobira cost?

It is understood that the price of Respimat was relatively expensive when it was first launched in China. Later, the price was reduced when it entered the medical insurance market. However, it is not as cheap as the foreign version!

Therefore, what is worth telling you here is that each box sold abroad is around 170$, which is relatively affordable. Due to the floating exchange rate, the price is different. Please consult Medical Travel for specific prices!

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: